Search filters

List of works by Filippo Montemurro

"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome.

scientific article published on 18 February 2016

2013 San Antonio Breast Cancer Symposium

scientific article published on 03 April 2014

A computer-aided diagnosis (CAD) scheme for pretreatment prediction of pathological response to neoadjuvant therapy using dynamic contrast-enhanced MRI texture features.

scientific article

A new player in the treatment of HER2-positive tumours

scientific article published on 29 April 2019

A retrospective analysis of the activity and safety of oral Etoposide in heavily pretreated metastatic breast cancer patients

scientific article published on 15 March 2015

AKT signaling in ERBB2-amplified breast cancer

scientific article published on 29 November 2015

Accelerated partial breast irradiation using 3D conformal radiotherapy: toxicity and cosmetic outcome.

scientific article published on 16 August 2013

Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives.

scientific article published on 12 April 2013

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

scientific article

Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?

scientific article published on 28 November 2017

Attrition in metastatic breast cancer: a metric to be reported in randomised clinical trials?

scientific article published on 01 January 2020

Biomarkers of drugs targeting HER-family signalling in cancer.

scientific article published on January 2014

Buparlisib , an oral pan-PI3K inhibitor for the treatment of breast cancer

scientific article

By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy.

scientific article

Changing paradigms in the treatment of hormone-receptor positive advanced breast cancer.

scientific article

Clinical utility of exemestane in the treatment of breast cancer

scientific article published on 27 May 2015

Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials

scientific article

Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey

scientific article published on 19 April 2018

Current status and future perspectives in the endocrine treatment of postmenopausal, hormone receptor-positive metastatic breast cancer ⬇️

scientific article published on October 1, 2012

Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study.

scientific article published on 25 August 2015

Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

scientific article published on 13 November 2019

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.

scientific article published on 9 December 2016

Duration of trastuzumab for HER2-positive breast cancer.

scientific article published on 11 June 2013

Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter study.

scientific article published on 18 March 2017

Endocrine therapy in premenopausal women with breast cancer: a critical appraisal of current evidence

scientific article

Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer

scientific article

Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial-a multicenter retrospective study of eribulin in real life

scientific article

Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.

scientific article published on 21 April 2017

Exploratory analysis of circulating cytokines in patients with metastatic breast cancer treated with eribulin: the TRANSERI-GONO (Gruppo Oncologico del Nord Ovest) study

scientific article published on 01 October 2020

Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases.

scientific article published on 9 October 2017

HER2 expression and efficacy of T-DM1

scientific article published on 3 December 2014

HER2-positive metastatic breast cancer: a changing scenario

scientific article

Human epidermal growth factor receptor 2 (HER2)-positive and hormone receptor-positive breast cancer: new insights into molecular interactions and clinical implications.

scientific article published on August 2013

Immunophenotypic heterogeneity of hyalinizing trabecular tumours of the thyroid ⬇️

scientific article published on 01 December 1997

Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer.

scientific article published on 18 November 2017

Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medica

scientific article published on 08 August 2019

Interaction of CDCP1 with HER2 enhances HER2-driven tumorigenesis and promotes trastuzumab resistance in breast cancer

scientific article published on 16 April 2015

Investigational ErbB-2 tyrosine kinase inhibitors for the treatment of breast cancer

scientific article published on 10 February 2016

Linifanib: current status and future potential in cancer therapy

scientific article published on 02 May 2015

Metastatic breast cancer subtypes and central nervous system metastases

scientific article published on 30 June 2014

Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM).

scientific article

MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer

scientific article published on 01 October 2020

Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function

scientific article published in October 2017

Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)

scientific article published on 09 October 2018

New and developing chemical pharmacotherapy for treating hormone receptor-positive/HER2-negative breast cancer.

scientific article published on 20 September 2016

Omission of axillary dissection after a positive sentinel lymph-node: Implications in the multidisciplinary treatment of operable breast cancer

scientific article published on 24 May 2016

Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series.

scientific article published on 29 January 2018

Pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy

scientific article published on 28 June 2014

Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study

scientific article

Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study.

scientific article published on 22 June 2015

Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study

scientific article published on 11 April 2017

Percutaneous Vertebroplasty in Osteoporotic Patients: An Institutional Experience of 1,634 Patients with Long-Term Follow-Up ⬇️

scientific article published on October 22, 2011

Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer

scientific article published on 13 September 2013

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

scientific article

Primary tumor location predicts the site of local relapse after nipple-areola complex (NAC) sparing mastectomy.

scientific article published on 28 May 2017

Recent advances in the medical management of breast cancer: highlights from the 29th San Antonio Breast Cancer Conference San Antonio, TX, USA, 14-17 December 2007

Role of trastuzumab in the management of HER2-positive metastatic breast cancer.

scientific article

Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, [...]

scientific article

Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1

scientific article published on 29 January 2019

Safety profile of subcutaneous trastuzumab for the treatment of patients with HER2-positive early or locally advanced breast cancer: primary analysis of the SCHEARLY study

scientific article published on 03 November 2018

Selected highlights from the 26th San Antonio Breast Cancer Symposium. December 3-6, 2003, San Antonio, TX, USA

Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer.

scientific article published on 23 December 2015

Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study

scientific article published on 20 July 2018

Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials

scientific article published on 26 October 2019

T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer

scientific article published on 12 July 2018

Target achieved

The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment

scientific article published on 01 September 2018

Trastuzumab Beyond Progression in Retrospective Analyses: An Issue of Equal Opportunities ⬇️

scientific article published on March 10, 2011

Trastuzumab emtansine in HER2-positive metastatic breast cancer

scientific article published on 16 May 2017

Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison

scientific article

Trastuzumab-based combination therapy for breast cancer

scientific article published on January 2004

Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidity

scientific article published on 01 April 2019

Treating breast cancer with cell-based approaches: an overview.

scientific article

Upfront adjuvant aromatase inhibitors in women with lobular breast cancer.

scientific article published on 15 July 2013

Vertebral Augmentation with Nitinol Endoprosthesis: Clinical Experience in 40 Patients with 1-Year Follow-up ⬇️

scientific article published on May 8, 2013

Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study

scientific article

What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?

scientific article published on 06 November 2018

p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy

scientific article published on 21 December 2015

Paulina is supported by:

About Paulina

Help